BMY Related Momentum Movers
-
Bristol-Myers (BMY) Shares Volatile Amid Report of Subpoena Related to FCPA Probe
-
Achillion (ACHN) Shares Slammed, Gilead (GILD), Idenix (IDIX) Rip on New HCV Treatment Data
-
Amylin (AMLN) Shares Rally Into Close as WSJ Says Bristol (BMY) Still Looking at Co.
-
Analysts Expecting Higher Bids for Amylin (AMLN)
-
Amylin (AMLN) Shares Surge 50+% Amid Rumor Co. Rejected $3.5B Bid from Bristol (BMY)
-
VIVUS (VVUS) Could Be Bought For Up to $40/Share
-
Achillion (ACHN) Shares Rocked as BofA Cuts to Underperform
-
Achillion (ACHN) Higher on Further HCV Development, Inhibitex Buyout; Up ~10%
-
Bristol-Myers (BMY) Shares Pop as New Melanoma Drug Given US Approval
-
ZymoGenetics (ZGEN) Shares Resume Trading Up 78%
-
Medarex (MEDX) Higher After Experimental Drug Shows Dramatic Results
-
Exelixis (EXEL) Up 25% On Positive Brain Tumors Study
-
A Look at Yesterday's Momentum Movers: NEOL, NTRI, TALX, PETS, MDII, STAA, RGEN, NMGC
-
RGEN Higher on Word of Rights to BMY's Orencia
Back to BMY Stock Lookup
